Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury

被引:25
|
作者
Fernandez Rico, Carlota [1 ,2 ]
Konate, Karidia [3 ]
Josse, Emilie [3 ]
Nargeot, Joel [1 ,2 ]
Barrere-Lemaire, Stephanie [1 ,2 ]
Boisguerin, Prisca [3 ]
机构
[1] Univ Montpellier, Inst Gen Fonct, CNRS, INSERM, Montpellier, France
[2] Lab Excellence Channel Sci & Therapeut, Valbonne, France
[3] Univ Montpellier, PHYMEDEXP, CNRS, INSERM, Montpellier, France
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
myocardial infarction; ischemia-reperfusion injury; therapeutic peptide; pharmacological treatment; cardioprotection; ATRIAL-NATRIURETIC-PEPTIDE; MITOCHONDRIAL PERMEABILITY TRANSITION; PERCUTANEOUS CORONARY INTERVENTION; LIMITS INFARCT SIZE; ACUTE HEART-FAILURE; GLUCAGON-LIKE PEPTIDE-1; JAPAN-WORKING GROUPS; ISOLATED RAT-HEART; ISCHEMIA/REPERFUSION INJURY; CYCLOSPORINE-A;
D O I
10.3389/fcvm.2022.792885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases (CVD) including acute myocardial infarction (AMI) rank first in worldwide mortality and according to the World Health Organization (WHO), they will stay at this rank until 2030. Prompt revascularization of the occluded artery to reperfuse the myocardium is the only recommended treatment (by angioplasty or thrombolysis) to decrease infarct size (IS). However, despite beneficial effects on ischemic lesions, reperfusion leads to ischemia-reperfusion (IR) injury related mainly to apoptosis. Improvement of revascularization techniques and patient care has decreased myocardial infarction (MI) mortality however heart failure (HF) morbidity is increasing, contributing to the cost-intense worldwide HF epidemic. Currently, there is no treatment for reperfusion injury despite promising results in animal models. There is now an obvious need to develop new cardioprotective strategies to decrease morbidity/mortality of CVD, which is increasing due to the aging of the population and the rising prevalence rates of diabetes and obesity. In this review, we will summarize the different therapeutic peptides developed or used focused on the treatment of myocardial IR injury (MIRI). Therapeutic peptides will be presented depending on their interacting mechanisms (apoptosis, necroptosis, and inflammation) reported as playing an important role in reperfusion injury following myocardial ischemia. The search and development of therapeutic peptides have become very active, with increasing numbers of candidates entering clinical trials. Their optimization and their potential application in the treatment of patients with AMI will be discussed.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Myocardial ischemia-reperfusion injury: a neglected therapeutic target
    Hausenloy, Derek J.
    Yellon, Derek M.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01): : 92 - 100
  • [2] Mechanisms and therapeutic advances of myocardial ischemia-reperfusion injury
    张萌
    高山
    李丹阳
    饶宏宇
    South China Journal of Cardiology, 2022, 23 (01) : 14 - 18
  • [3] Flavonoids in myocardial ischemia-reperfusion injury: Therapeutic effects and mechanisms
    Jia, Jun-ying
    Zang, Er-huan
    Lv, Li-juan
    Li, Qin-yu
    Zhang, Chun-hua
    Xia, Ying
    Zhang, Lei
    Dang, Lian-sheng
    Li, Min-hui
    CHINESE HERBAL MEDICINES, 2021, 13 (01) : 49 - 63
  • [4] Flavonoids in myocardial ischemia-reperfusion injury: Therapeutic effects and mechanisms
    Jun-ying Jia
    Er-huan Zang
    Li-juan Lv
    Qin-yu Li
    Chun-hua Zhang
    Ying Xia
    Lei Zhang
    Lian-sheng Dang
    Min-hui Li
    Chinese Herbal Medicines, 2021, 13 (01) : 49 - 63
  • [5] Flavonoids in myocardial ischemia-reperfusion injury: Therapeutic effects and mechanisms
    Junying Jia
    Erhuan Zang
    Lijuan Lv
    Qinyu Li
    Chunhua Zhang
    Ying Xia
    Lei Zhang
    Liansheng Dang
    Minhui Li
    Chinese Herbal Medicines, 2021, (01) : 49 - 63
  • [6] Peroxynitrite in myocardial ischemia-reperfusion injury
    Lalu M.M.
    Wang W.
    Schulz R.
    Heart Failure Reviews, 2002, 7 (4) : 359 - 369
  • [7] Myocardial ischemia-reperfusion injury in hyperinsulinemia
    Gibson, MF
    Farinas, L
    Strange, MB
    Lefer, DJ
    FASEB JOURNAL, 2001, 15 (04): : A462 - A462
  • [8] Statin and myocardial ischemia-reperfusion injury
    Hu, Jun
    Lu, Yao
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 988 - 988
  • [9] Flavonoids for Myocardial Ischemia-Reperfusion Injury?
    Birnbaum, Yochai
    Vilahur, Gemma
    CARDIOVASCULAR DRUGS AND THERAPY, 2025,
  • [10] Therapeutic Potential of a Novel Necrosis Inhibitor in Myocardial Ischemia-reperfusion Injury
    Cho, Hyun-Jai
    Hwang, In-Chang
    Kim, Ju-Young
    Lee, Hak Seung
    Lee, Jaewon
    Park, Jonghanne
    Yang, Han-Mo
    Kwon, Yoo-Wook
    Kim, Soon-Ha
    Kim, Hyo-Soo
    CIRCULATION RESEARCH, 2015, 117